top of page

Vaccine-Preventable Diseases

The Vaccine-Preventable Diseases Committee addresses global immunization challenges and the continued spread of diseases that can be prevented through vaccination. It promotes stronger immunization programmes, equitable vaccine access, public awareness, and evidence-based communication to combat vaccine hesitancy, improve protection for vulnerable communities, and prevent future infectious disease outbreaks.

Vaccine-Preventable Diseases — Committee 11 of 12

14

Countries Represented

21

Member Organizations

Evidence

Policy in Action

Stronger

Together for Impact

Objectives

Objectives

Our objectives define the goals that guide each committee's work, providing a clear direction for its activities. They help focus collective efforts, encourage collaboration, and turn shared ambitions into meaningful action.

Advocacy

Coordinate civil society advocacy for immunisation policy at WHO, EU, and national levels.

Coalition-building

Connect diverse regional partners around shared vaccination priorities.

Vaccine confidence

Address vaccine hesitancy through clear communication and community engagement.

Evidence

Share evidence on disease burden, vaccination gaps, and equity barriers.

Financing

Mobilise and monitor funding for immunisation programmes worldwide.

Equity

Close vaccination gaps for marginalised, migrant, and displaced communities.

Policy Priorities

Priorities

Explore the key policy priorities that shape the committee’s strategic direction and guide its efforts to address pressing global health challenges. These priorities focus on strengthening collaboration, advancing evidence-based policies, promoting equitable and sustainable solutions, and translating shared goals into practical actions that support meaningful progress and lasting impact.

Close Routine Immunisation Gaps

Close routine vaccination gaps among underserved and vulnerable people.

Advancing Immunization Equity

Expand vaccine access for underserved, migrant, and displaced communities.

Life-Course Immunization

Support vaccination throughout life, including infancy and adulthood.

Safeguarding Immunization Financing

Protect sustainable funding for immunisation programmes and infrastructure.

Countering Vaccine Misinformation

Counter misinformation through evidence and community engagement.

Strengthening Health Systems

Embed vaccination in stronger health systems and community services.

Facts

Explore essential facts, research findings, and evidence that highlight the key challenges, emerging trends, and developments within the committee’s field. These insights provide a clearer understanding of current issues, support informed decision-making, and help identify priorities for effective action and long-term improvements in global health.

Vaccines Save Lives

Vaccines have saved an estimated 154 million lives over 50 years.

Measles Cases at a 25-Year High

Europe reported 127,350 measles cases in 2024, its highest level since 1997.

Protection Against 30+ Diseases

Vaccines protect against more than 30 life-threatening diseases.

14.3 Million Zero-Dose Children

Over 14.3 million infants received no basic routine vaccines in 2024.

Members

Margaret Happy

Country Lead – Uganda

AFROCAB

Wishes Mumba

Communications Lead

COWLHA

Henrique Fonseca

Immunology & Vaccines

Einstein Hospital Israelita

Larry Holden

President & CEO

Global Liver Institute (GLI)

Dr Tim Reed

President & CEO

Health Action International

Dr. S. M. Mursalin

National Adviser

Pak One Health alliance

Dr Fatou Fall Ndoye

Executive Director

Askaan Sante

Vivian Ben Obiagwu

Executive Director

Bethel Viva Foundation

Pedro Barata

Vice President

EMSA

Alexandra Castro Silva

Secretary General

EMSA

Lillian Kreppel

Co-Founder

HPV Cancers Alliance

Beno Huglin Mbeya

Research Scientist

Ifakara Health Institute

Nenad Miljkovic

President

EAHP

King Solomon Martin

Nursing supretender

FRH-DONGA

Edna Tembo

Executive Director

COWLHA

Mikaela Nordenfelt

Director

ESWI

Rohit Malpani

ndependent Consultant

GARDP

Isabella Johnson

Assistant Instructor

HPVCA

Birgit Poniatowski

Executive Director

IAS

Chika Offor

Chief Executive Officer

VNDC

Dr Ishwar Gilada

HIV/ID Consultant

Unison Medicare

Guests

Najiba M. Abdulrazzaq

Head of Infection Prevention

EHS

Chetan Sharma

Surveillance Medical Officer

Indipendent

Richard Corfneille Lupasu

Public Health Expert

Independent

Leadership

Emily Gellert

Committee Manager

Vaccine-Preventable Diseases

Events

bottom of page